Morris and Dickson

What Morris and Dickson does

Morris & Dickson Co., LLC is the largest independently owned full-line and specialty pharmaceutical distributor in the United States, founded in 1841 and headquartered in Shreveport, Louisiana. The company distributes brand-name drugs, generics, plasma-derived therapies, biologics, biosimilars, vaccines, OTC products, and home health supplies to health systems, independent pharmacies, specialty pharmacies, physician-owned clinics, infusion centers, and alternate care facilities across all 50 states, reporting more than $7 billion in annual sales and offering over 30,000 SKUs from a single location.

Operations are anchored by a 450,000-square-foot automated distribution center in Shreveport and a second 97,200-square-foot facility under development in Olive Branch, Mississippi, with over 90% of order lines picked through automation at a 1-in-60,000 error rate and an owned fleet traveling 150,000+ miles per day for next-day delivery. Advanced cold chain capabilities span storage down to -80°C using Aerosafe Global and Coldtainer systems with real-time temperature monitoring, supported by 46,400 cubic feet of secured Bio Box specialty storage and over 1,200 cold locations. Customer-facing technology includes the Prodigy Vision portal for real-time inventory and ordering, Prodigy Connect RFID/IntelliGuard smart-cabinet consignment monitoring, Prodigy 360 DSCSA compliance tooling, and the Cervey technology platform for 340B program management.

The business model combines wholesale pharmaceutical distribution (transaction-fee revenue), specialty distribution of limited-distribution drugs and biologics, third-party logistics services for manufacturers via PresaMD, and a specialty GPO (BeaconMD) providing transparent drug purchasing for clinics and infusion centers. Recent acquisitions of Presa Solutions (2025) and Prodigy Health (2026), a Johnson & Johnson specialty-drug supply agreement, and a partnership with Mark Cuban Cost Plus Drug Company extend the platform into 3PL services, plasma-derived therapies, and direct injectables distribution. Distribution is NABP-accredited and HDA-affiliated, with a dedicated account-specialist sales model serving the pharmacy and healthcare-provider market.

Name

Morris and Dickson

Legal name

Morris & Dickson Co. LLC

Website

https://morrisdickson.com

Company type

Private

Founded year

1841

Operating status

Operating

Headcount range

251–500 employees

Short description

Morris & Dickson is the largest independently owned US full-line and specialty pharmaceutical distributor, distributing brand, generic, and specialty drugs to health systems, independent pharmacies, specialty pharmacies, clinics, and infusion centers across all 50 states, with over $7 billion in annual sales.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Pharmaceutical wholesale distribution
• Specialty drug distribution
• Pharmaceutical cold chain
• Pharmacy supply services
• Generic drug sourcing

Headquarters

HQ city

Shreveport

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Full-Line Pharmaceutical Distribution: Distribution of brand name drugs, generics, OTC products, and home health products to health systems, independent pharmacies, specialty pharmacies, and alternate care facilities across the United States.
2. Specialty Pharmaceutical Distribution: Distribution of limited distribution drugs (LDDs), exclusive drugs, plasma-derived therapies, biologics, biosimilars, and specialty medications requiring cold chain handling to qualified institutional, hospital, and specialty retail pharmacies.
3. Third-Party Logistics (3PL) Services: Order management, invoicing, deductions management, full financial reporting, contract and chargeback administration, flash title distribution, and DSCSA preparedness for pharmaceutical manufacturers through PresaMD.
4. Specialty GPO Services: Group purchasing organization services through BeaconMD providing transparent drug purchasing models and competitive contract pricing for specialty clinics and infusion centers.
5. Specialty Injectable Distribution Partnership: Partnership with Mark Cuban Cost Plus Drug Company to distribute injectable medications, ensuring steady availability of rare drugs and lower costs for healthcare providers.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Morris & Dickson is the largest independent full-line and specialty pharmaceutical distributor in the United States, providing next-day delivery of brand name, generic, specialty, plasma/biologic, biosimilar, vaccine, OTC, and home health products to health systems, independent pharmacies, specialty pharmacies, clinics, infusion centers, and alternate care facilities. The company also provides specialty GPO services through BeaconMD, third-party logistics (3PL) services for pharmaceutical manufacturers through PresaMD, and technology solutions (340B, DSCSA, inventory) through Cervey and the Prodigy suite.

Product overview

Morris & Dickson is the largest independent full-line and specialty pharmaceutical distributor offering reliable next-day delivery of drugs and related products. The core offering centers on the M&D Web Portal for ordering and the M&D Specialty Distribution (MDSD) platform with advanced cold chain capabilities. The product portfolio includes Brand Name pharmaceuticals, Generics, Plasma & Biologics, Biosimilars, Vaccines, OTC products, and Home Health items distributed to health systems, independent pharmacies, specialty pharmacies, physician-owned clinics, infusion centers and alternative care facilities. The company operates several subsidiary brands: ProdigyMD (acquired specialty distributor focused on plasma-derived therapies with Prodigy Vision Portal, Prodigy Connect RFID, Prodigy OnDemand consignment, and Prodigy 360 DSCSA compliance), BeaconMD (specialty Group Purchasing Organization for clinics and infusion centers), PresaMD (acquired 3PL services for order management and chargeback administration), and Cervey (technology solutions for 340B program management and DSCSA data management). The company holds over 30,000 pharmaceutical and healthcare SKUs from a single location, with expansion of specialty handling capacity including dedicated refrigerated areas and Aerosafe/Coldtainer cold chain capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Full-Line Pharmaceutical Distribution Wholesale distribution of brand name drugs, generic drugs, OTC products, and home health products to health systems, independent pharmacies, specialty pharmacies, and alternate care facilities across the United States, with next-day delivery from a single 450,000-square-foot automated distribution center.
• Specialty Pharmaceutical Distribution (M&D Specialty Distribution / MDSD) Distribution of limited distribution drugs (LDDs), exclusive drugs, plasma-derived therapies, biologics, biosimilars, and specialty medications requiring cold chain handling (down to -80°C) to qualified institutional, hospital, and specialty retail pharmacies, supported by 46,400 cu. ft. of secured cold storage and ultra-cold chain capability.
• Plasma-Derived Therapies Distribution (ProdigyMD) Specialty pharmaceutical distribution of plasma-derived therapies (IVIG, Albumin, Hyperimmune Globulin, Coagulants, Hemophilia Factor) to hospitals, specialty pharmacies, infusion centers, and clinics, delivered through the ProdigyMD portal with same-day delivery and consignment services.
• Specialty GPO Services (BeaconMD) Specialty Group Purchasing Organization connecting specialty pharmacies, independent specialty clinics, and infusion providers to therapies, pricing, and support across immunology, oncology, neurology, gastroenterology, and rare disease therapeutic areas, with competitive contract pricing and access to limited distribution products.
• Third-Party Logistics Services (PresaMD) Third-party logistics services for pharmaceutical manufacturers including order management, invoicing, collections, deductions management, financial reporting, contract and chargeback administration, flash title distribution, and DSCSA preparedness through the PresaMD order-to-cash platform.
• Consignment Services Consignment inventory programs that allow healthcare facilities to stock specialty medications without upfront purchase, reducing waste, eliminating expiry risk, and improving availability of high-cost variable-use drugs.
• Generic Sourcing Program Dynamic generics sourcing program utilizing RFP practices to review items, increase savings, and expand portfolio options, providing access to cost savings directly from manufacturers on a dynamic portfolio of generic drugs.
• Secondary Distribution Services Distribution services supporting secondary sales and fulfillment for pharmaceutical manufacturers beyond primary distribution channels, including support for the planned Olive Branch, MS distribution center focused on secondary distribution.
• Technology Solutions (Cervey) Technology solutions for health systems, specialty pharmacies, and sites of care covering 340B program management, DSCSA data management, and workflow optimization tools.
• 503B Outsourced Compounding Services Sales, service, and distribution partnership providing compounded sterile preparations from an FDA-registered 503B outsourcer (Leiters) to health systems and specialty pharmacies.
• Brand Name Pharmaceuticals Full portfolio of brand-name pharmaceutical products distributed to health systems, pharmacies, and care facilities.
• Generic Pharmaceuticals Generic pharmaceutical products with competitive pricing and extensive inventory from the centralized Shreveport distribution center.
• Plasma & Biologics Plasma-derived products and biologics including IVIG, Albumin, Hyperimmune Globulin, Coagulants, and Hemophilia Factor distributed through ProdigyMD.
• Biosimilars Biosimilar pharmaceutical products offering cost-effective alternatives to reference biologics.
• Vaccines Vaccine products distributed across the United States including routine immunizations and specialty vaccines with cold chain handling.
• Over the Counter (OTC) Over-the-counter pharmaceutical and healthcare products for retail pharmacy distribution.
• Home Health Products Products and supplies for home healthcare settings and home-based patient care.

Quantifiable outcome

• Error rate of 1 in 60,000 through automation, significantly better than industry rate of 1 in 6,000
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eight partnerships are on record, tiered core and strategic.

• Prodigy Health (now ProdigyMD)coreStrategic or Co-development Partner · 30 January 2026Acquisition completed in January 2026. Prodigy Health is a specialty pharmaceutical distribution company focused on plasma-derived therapies. The acquisition strengthens Morris & Dickson's specialty portfolio and expands ability to serve alternative sites of care including hospitals, specialty pharmacies, clinics, and infusion centers nationwide. Prodigy Health operates under the name ProdigyMD.
• Presa SolutionsstrategicStrategic or Co-development Partner · 3 April 2025Acquisition of virtual third-party logistics (3PL) provider for pharmaceutical manufacturers. The acquisition integrates Presa Solutions' innovative order-to-cash platform with Morris & Dickson's existing logistics network, supporting biotech and pharmaceutical clients. Now operating as PresaMD.
• Johnson & JohnsonstrategicTechnology or Integration · 23 January 2025Agreement to expand specialty distribution portfolio by adding over 50 new specialty drugs including Darzalex, Stelara, Remicade, Simponi, Tremfya, Zytiga, Invega, Monovisc, Orthovisc, Procrit, Risperdal, and Xarelto. Enhances company's ability to support oncology, rheumatology, and rare disease treatments.
• BeaconMDcoreChannel Partner/ Reseller/ Distributor · 1 July 2024Five-year, non-exclusive distribution agreement where BeaconMD (a GPO) brings high-value drug pricing programs to community sites of care nationwide. Morris & Dickson supports BeaconMD members with next-day fulfillment services of specialty products, including cold chain packaging through Aerosafe Global.
• Mark Cuban Cost Plus Drug Company (MCCPDC)coreStrategic or Co-development Partner · 1 January 2024Partnership established in 2024 to improve access to injectable medications and supply chain efficiency. The partnership aims to ensure steady availability of rare drugs and lower costs for healthcare providers. Morris & Dickson serves as a specialty pharmaceutical distributor partner for MCCPDC's injectable medication portfolio.
• PfizerstrategicTechnology or IntegrationPharmaceutical supplier partner for specialty distribution portfolio. Part of contracts with significant pharmaceutical suppliers including Johnson & Johnson, Pfizer, and Genentech.
• GenentechstrategicTechnology or IntegrationPharmaceutical supplier partner for specialty distribution portfolio. Part of contracts with significant pharmaceutical suppliers including Johnson & Johnson, Pfizer, and Genentech.
• Aerosafe GlobalstrategicTechnology or IntegrationCold chain packaging solution provider for temperature control and tracking throughout pharmaceutical payload journey. Ensures patient safety and reduces packaging waste.

Scale indicators12 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• McKesson Corporation: McKesson is the largest U.S. pharmaceutical distributor with full-line and specialty distribution across branded, generic, and specialty products. It directly competes with Morris & Dickson for health systems, retail pharmacies, and specialty distribution contracts, though at far greater scale.
• Cencora (formerly AmerisourceBergen): Cencora is one of the Big 3 U.S. pharmaceutical distributors and a major player in specialty distribution (through its US Bioservices and Specialty Provider Services). It competes directly with Morris & Dickson's full-line and specialty businesses for manufacturer contracts and downstream pharmacy/health-system customers.
• Cardinal Health: Cardinal Health operates one of the largest U.S. pharmaceutical and medical product distribution networks, including specialty distribution (Cardinal Health Specialty Solutions). It is a direct competitor to Morris & Dickson in serving retail pharmacies, hospitals, and specialty providers nationwide.
• Smith Drug Company: Smith Drug Company is a privately held full-line pharmaceutical wholesaler serving independent and regional pharmacy customers. It is the closest independent analog to Morris & Dickson in terms of customer focus (independents and regionals) and absence of Big 3 ownership.
• Anda, Inc. Anda is Teva's U.S. pharmaceutical distribution business, distributing generic, brand, and specialty products to retail pharmacies, hospitals, and alternate care sites. It is comparable as a specialty/generic-capable distributor competing for similar end customers.
• BioCareSD: BioCareSD is an independent specialty pharmaceutical distributor focused on limited distribution drugs, plasma/bio products, and specialty therapies to specialty pharmacies and providers. It is directly comparable to Morris & Dickson's MDSD and ProdigyMD specialty operations.

Broad incumbents

• ClarusONE Sourcing Services: ClarusONE is a joint venture between Walmart and McKesson that negotiates generic procurement at scale. It is comparable as a competitor in generic sourcing/wholesale that pressures independent distributors like Morris & Dickson on generics economics.

Regional players

• Mutual Drug Company: Mutual Drug is an independent regional pharmaceutical wholesaler serving member pharmacies across the Southeastern United States. It overlaps with Morris & Dickson's traditional south-central footprint and independent pharmacy customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/morrisdicksonco

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Morris and Dickson